ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

AACR Polls Members On Tentative Date for Annual Meeting

April 11, 2003

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998

NCI Urged To Back Ultrasounds Studies

October 1, 1976

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994